CYTK Stock Cash Flow Statements

Cytokinetics Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Cytokinetics Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-08-05	2012-08-05	2011-08-05	2010-08-05	2008-08-05	2007-08-05

cash flows from operating activities:
net income	-134,370,000	-161,376,000	-150,020,000	-160,545,000	-143,318,000	-135,643,000	-136,896,000	-129,422,000	-128,637,000	-131,289,000	-137,380,000	-142,310,000	-19,820,000	-89,445,000	-30,570,000	-76,086,000	-61,554,000	-47,104,000	-43,930,000	-3,175,000	-40,780,000	-39,405,000	-30,640,000	-29,573,000	-32,113,000	-29,366,000	-26,468,000	-22,017,000	-27,523,000	-30,281,000	-40,485,000	-32,357,000	-29,081,000	-25,867,000	8,632,000	31,887,000	-11,611,000	-12,455,000	-9,229,000	-8,849,000	-10,551,000	-8,872,000	8,443,000	-5,971,000	-8,374,000	-8,744,000	6,531,000	-12,619,000	-9,928,000	-13,155,000	-12,189,000	-17,566,000	-11,692,000
adjustments to reconcile net income to net cash from operating activities:
non-cash interest expense on liabilities related to revenue participation right purchase agreements	13,207,000	14,104,000		13,396,000	11,593,000	10,244,000		6,886,000	6,349,000	6,313,000		8,994,000	7,031,000	6,592,000
stock-based compensation expense	27,535,000	23,549,000	26,250,000	25,356,000	24,622,000	21,612,000	19,487,000	18,716,000	18,668,000	15,194,000	13,498,000	13,175,000
non-cash lease expense	1,336,000	1,230,000	1,162,000	1,103,000	1,054,000	995,000	942,000	937,000	936,000	935,000	1,083,000	680,000	595,000	227,000	1,954,000
depreciation of property and equipment	2,285,000	2,300,000	2,383,000	2,411,000	2,406,000	2,331,000	6,335,000	1,854,000	1,855,000	1,848,000	1,658,000													336,000	280,000	286,000		268,000	618,000	673,000
change in fair value of derivative liabilities	-3,000,000	400,000	-1,200,000	-700,000
change in fair value of liabilities related to rpi transactions	14,600,000	-3,900,000	4,600,000	15,200,000
realized gain on investment
interest receivable and amortization on investments	-4,032,000	-6,174,000	-7,701,000	-11,091,000	-8,499,000	-5,224,000	-5,101,000	-3,736,000	-3,861,000	-3,037,000	-4,218,000	-2,038,000	542,000	1,004,000	1,454,000	1,424,000	1,083,000	933,000	-792,000	-429,000	-266,000	293,000	-1,004,000	-375,000	-675,000	-533,000	-440,000	-737,000	-596,000	96,000
non-cash interest expense related to debt	5,330,000	3,453,000	3,532,000	3,486,000	2,662,000	1,879,000	-13,609,000	7,079,000	6,983,000	6,888,000	1,088,000	1,967,000	1,342,000	1,300,000	1,875,000	1,825,000	1,749,000	1,676,000	1,691,000	1,648,000	1,577,000	1,724,000	112,000	291,000	333,000	183,000
changes in operating assets and liabilities:
accounts receivable	-6,398,000	14,638,000	-16,406,000	-244,000	834,000	449,000	1,216,000	-1,514,000	21,000	-859,000	2,147,000	-321,000	4,083,000	50,763,000	-51,175,000	2,057,000	1,813,000	-94,000	545,000	-2,711,000	450,000	2,459,000	1,413,000	2,417,000	-4,828,000	-1,934,000	6,925,000	-8,920,000	-199,000	1,075,000	8,888,000	-10,000,000
prepaid and other assets	-4,637,000	-376,000	-8,444,000	4,475,000	8,161,000	-6,630,000	8,533,000	342,000	-5,652,000	-1,627,000	1,528,000	-909,000	-6,611,000	-1,422,000	3,863,000	-5,663,000	-8,258,000	2,677,000			-1,109,000	949,000	-2,117,000	-1,479,000	717,000	-983,000	-209,000	-162,000	782,000	1,406,000	147,000	355,000	-1,424,000	-1,239,000	215,000	3,678,000	-3,558,000	-1,042,000	830,000	-211,000	-299,000	-716,000	547,000	205,000	-418,000	-60,000	74,000	684,000	45,000	-1,400,000	394,000	-472,000	121,000
accounts payable	950,000	-4,576,000	5,905,000	1,717,000	-1,811,000	-10,294,000	7,711,000	1,235,000	-4,323,000	-8,106,000	13,048,000	3,406,000	-8,850,000	-3,080,000	3,857,000	-422,000	1,667,000	-4,047,000	1,312,000	3,818,000	-607,000	-4,633,000	4,748,000	-1,782,000	2,647,000	-1,217,000	1,740,000	688,000	-1,087,000	-2,831,000	-5,000	3,350,000	-1,162,000	-726,000	3,032,000	-2,175,000	2,303,000	-1,462,000	139,000	305,000	216,000	95,000	-315,000	657,000	-407,000	-2,113,000	1,759,000	-800,000	-257,000	-143,000	102,000	874,000	-490,000
deferred revenue											0	0															7,252,000	-4,165,000	-7,841,000	-1,731,000	-870,000	2,434,000	-2,966,000	2,915,000	-3,073,000	11,299,000	-1,929,000	-4,095,000	-4,854,000	-3,574,000	-2,867,000	-1,447,000	28,264,000	-3,648,000	-2,184,000	-5,033,000	-19,817,000			797,000	-534,000	-9,993,000	3,876,000
accrued and other liabilities	13,985,000	-14,367,000	10,077,000	5,511,000	4,173,000	-5,579,000	32,129,000	4,155,000	-11,426,000	-7,755,000	-351,000	8,638,000	6,079,000	-3,522,000	1,239,000	10,787,000	6,154,000	-3,120,000	1,472,000	4,191,000	2,518,000	-1,064,000	-265,000	1,320,000	-757,000	-2,466,000	46,000	-512,000	-2,664,000	1,067,000	898,000	3,780,000	-4,063,000	151,000	-177,000	7,979,000	1,508,000	-365,000	1,654,000	759,000	2,000,000	-1,418,000	-636,000	-904,000	-765,000	-560,000	-1,639,000	-103,000	404,000
operating lease liabilities	-2,323,000	-2,143,000	-2,025,000	-1,815,000	-1,692,000	-1,712,000	-1,134,000	-78,000	-74,000	-120,000	671,000	1,114,000	522,000	-579,000	10,006,000			9,816,000	-1,235,000	-1,206,000	-1,139,000	-1,112,000	-1,022,000	-1,000,000	-938,000	-916,000
other non-current liabilities	-1,662,000	1,621,000	237,000	240,000	102,000	-1,935,000	-3,576,000	-2,659,000	-2,645,000	-705,000	-203,000	-197,000	-1,990,000	-1,668,000	-1,826,000
net cash from operating activities	-128,236,000	-131,617,000	-65,570,000	-101,500,000	-99,313,000	-129,507,000	-74,037,000	-96,205,000	-121,805,000	-122,286,000	-98,190,000	-84,040,000	-90,475,000	-26,811,000	-44,737,000	-38,770,000	-29,496,000	-29,519,000	52,150,000	14,367,000	-27,439,000	-30,135,000	-19,055,000	-20,268,000	-24,677,000	-26,907,000	-12,327,000	-32,235,000	-26,846,000	-29,807,000	-24,071,000	-25,483,000	-31,261,000	-20,944,000	77,829,000	-12,122,000	-11,218,000	-17,507,000	-9,942,000	-10,347,000	-9,187,000	34,359,000	-8,130,000	-9,515,000	-9,376,000	-17,822,000	-12,429,000	-12,222,000	-8,737,000	-13,178,000	-12,208,000	-66,407,000	34,729,000
capex	-2,809,000	-4,170,000	1,593,000	-307,000	-1,686,000	1,754,000	-77,000	-220,000	-717,000	71,000	-4,450,000	-9,386,000	2,235,000	887,000	-16,746,000	-13,984,000	-3,297,000	-2,863,000	-6,555,000	-2,592,000	-864,000	-1,041,000	-1,306,000	-1,006,000	-50,000	-257,000	-210,000	-358,000	-60,000	-261,000	-780,000	-451,000	-258,000	-1,388,000	-854,000	-306,000	-16,000	-420,000	-204,000	-53,000	-175,000	-130,000	-247,000	-100,000	-424,000	-333,000	-252,000	-177,000	-13,000	-163,000	-154,000	1,088,000	-1,655,000
free cash flows	-131,045,000	-135,787,000	-63,977,000	-101,807,000	-100,999,000	-127,753,000	-74,114,000	-96,425,000	-122,522,000	-122,215,000	-102,640,000	-93,426,000	-88,240,000	-25,924,000	-61,483,000	-52,754,000	-32,793,000	-32,382,000	45,595,000	11,775,000	-28,303,000	-31,176,000	-20,361,000	-21,274,000	-24,727,000	-27,164,000	-12,537,000	-32,593,000	-26,906,000	-30,068,000	-24,851,000	-25,934,000	-31,519,000	-22,332,000	76,975,000	-12,428,000	-11,234,000	-17,927,000	-10,146,000	-10,400,000	-9,362,000	34,229,000	-8,377,000	-9,615,000	-9,800,000	-18,155,000	-12,681,000	-12,399,000	-8,750,000	-13,341,000	-12,362,000	-65,319,000	33,074,000
cash flows from investing activities:
purchases of investments	-222,966,000	-159,105,000	-121,125,000	-214,401,000	-815,235,000	-142,655,000	-226,115,000	-117,725,000	-201,592,000	-89,779,000	-125,179,000	-467,177,000	-69,910,000	-193,127,000	-31,592,000	-321,589,000	-105,661,000	-66,200,000	-269,278,000	-138,681,000	-17,274,000	-10,592,000	-136,085,000	-41,637,000	-58,866,000	-41,295,000	-51,796,000	-56,220,000	-107,984,000	-24,224,000	-25,956,000	-12,926,000	-68,761,000	-132,770,000	-65,189,000	-9,260,000	-20,563,000	-50,146,000	-20,908,000	-29,003,000	-15,815,000	-49,840,000	-13,799,000	-5,557,000	-32,217,000	-55,470,000	-11,148,000	-7,761,000	-10,747,000	11,255,000	-36,393,000	17,000,000	-26,400,000
investment in non-marketable equity security	0	-5,000,000
maturities and paydown of investments
sales of investments							-2,000	0	0	4,977,000					0	0	0	3,300,000
purchases of property and equipment	-4,145,000	-5,664,000	-1,290,000	-701,000			-77,000	-220,000	-717,000	-402,000	-3,205,000	-6,331,000	-857,000	-942,000	-17,754,000	-15,700,000	-8,792,000	-6,626,000	-6,555,000	-2,592,000	-864,000	-1,041,000	-1,306,000	-1,006,000	-50,000	-257,000	-210,000	-358,000	-60,000	-261,000	-780,000	-451,000	-258,000	-1,388,000	-854,000	-306,000	-16,000	-420,000	-204,000	-53,000	-175,000	-130,000	-247,000	-100,000	-424,000	-333,000	-252,000	-177,000	-13,000	-163,000	-154,000	1,088,000	-1,655,000
net cash from investing activities	52,881,000	105,956,000	110,863,000	-45,053,000	-651,548,000	32,641,000	-81,411,000	73,039,000	82,128,000	165,497,000	29,249,000	-292,372,000	65,268,000	-64,279,000	47,335,000	-208,717,000	18,881,000	-5,276,000	-173,618,000	-101,023,000	34,637,000	43,489,000	-105,266,000	13,682,000	-2,767,000	19,644,000	26,508,000	2,677,000			30,763,000	39,658,000	-23,949,000	-112,300,000	-41,970,000	13,971,000	-3,916,000	-20,161,000	25,411,000	11,306,000	11,439,000	-32,093,000	6,304,000	10,067,000	8,440,000	-28,860,000	5,813,000	10,470,000	5,052,000	7,539,000	4,704,000	798,000	2,931,000
cash flows from financing activities:
repayment of finance lease liabilities	-2,000	-202,000	-243,000	-236,000	-233,000	-227,000	-222,000	-217,000	-212,000	-207,000	-105,000	-424,000	-267,000	-148,000
repayment of term loans	-2,696,000	-2,682,000	-2,671,000	-2,658,000
proceeds from rpi transactions			0	0
proceeds from issuance of common stock related to at-the-market offering, net of issuance costs			0	0	0	93,640,000	162,921,000
proceeds from issuance of common stock related to public offering, net of issuance costs			0	0
proceeds from issuance of common stock related to private placement, net of issuance costs			0	0
proceeds from issuance of common stock under equity incentive and stock purchase plans	6,745,000	7,651,000	6,480,000	6,319,000	10,685,000	29,532,000	6,101,000	3,124,000	5,687,000	3,547,000
taxes paid related to net share settlement of equity awards	-514,000	-13,000	-1,182,000	0	0	-18,449,000	0	0	0	-10,517,000
net cash from financing activities	78,533,000	4,754,000	2,384,000	3,425,000	821,011,000	103,791,000	168,800,000	54,219,000	5,475,000	-7,177,000	29,885,000	389,019,000	3,416,000	93,846,000	19,506,000	300,895,000	3,175,000	-3,596,000	3,641,000	226,334,000	4,160,000	-11,000	121,120,000	11,859,000	22,396,000	4,416,000	451,000	10,227,000	2,978,000	-524,000	2,194,000	1,434,000	106,557,000	115,734,000	715,000	727,000	589,000	14,861,000	23,645,000	164,000	41,000	65,000	9,134,000	0	35,000	39,780,000	7,516,000	5,000	2,667,000	16,740,000	2,658,000	-28,755,000	27,001,000
effect of exchange rate changes on cash	-682,000	-270,000		-126,000
net increase in cash, cash equivalents, and restricted cash	2,496,000	-21,177,000	47,969,000	-143,254,000	70,166,000	6,952,000	13,332,000	31,053,000	-34,202,000	36,034,000
cash, cash equivalents, and restricted cash, beginning of period	0	95,232,000	0	0	0	113,399,000	0	0	0	67,182,000
cash, cash equivalents, and restricted cash, end of period	2,496,000	74,055,000	47,969,000	-143,254,000	70,166,000	120,351,000	13,332,000	31,053,000	-34,202,000	103,216,000
supplemental cash flow disclosures:
cash paid for interest	606,000	9,647,000	636,000	14,456,000	672,000	10,206,000	317,000	31,000	9,907,000	40,000	9,610,000	81,000	2,760,000	2,714,000
non-cash investing and financing activities:
right-of-use assets recognized in exchange for operating lease obligations	0	3,501,000	-28,000	198,000	133,000	178,000					8,592,000
amounts unpaid for purchases of property and equipment	1,336,000	1,494,000	2,883,000	394,000	-1,686,000	1,754,000				473,000	-1,245,000	-3,055,000	3,092,000	1,829,000	1,008,000	1,716,000	5,495,000	3,763,000
maturities of investments		275,725,000	233,278,000	170,049,000	165,602,000	175,296,000	144,783,000	190,984,000	284,437,000	250,701,000	157,633,000	181,136,000	136,035,000	129,790,000	96,681,000	128,572,000	133,334,000	64,250,000	99,154,000	40,250,000
non-cash interest expense on liabilities related to revenue participation right purchase agreement
loss on disposition of property and equipment
loss on extinguishment of debt											0	0	0	2,693,000
loss on inducement of convertible debt											0
debt extinguishment costs											0	0	0	-2,409,000
repayment of convertible debt											0
proceeds from issuance of convertible debt											0
cash settlement of capped call options associated with 2026 notes
effect of exchange rate changes						27,000
right-of-use assets recognized in exchange for finance lease obligations											0	0	352,000	703,000
issuance of common stock in connection with repurchase of convertible note											0
repayment of term loan						-705,000					0	0	0	-47,651,000
impairment of right-of-use assets
proceeds from public offerings of common stock, net of discounts, commissions and offering cost															0				0
proceeds from private placement																			0
proceeds from 2022 rpi transactions							0
loss on investments								0	1,000	34,000
gain on investment
claims settlement under section 16																			0	0	0	2,151,000
net increase in cash, cash equivalents, and restricted cash equivalents
cash, cash equivalents, and restricted cash equivalents, beginning of period
cash, cash equivalents, and restricted cash equivalents, end of period
proceeds from 2020 rpi transactions												0	0	149,581,000
proceeds from and payments for stock-based award activities												6,187,000	3,683,000	-5,527,000		3,990,000
net increase in cash and cash equivalents														2,756,000	22,104,000	53,408,000	-7,440,000	-38,391,000	-117,827,000	139,678,000	11,358,000	13,343,000					14,632,000	-19,331,000			8,886,000	15,609,000			36,574,000	2,576,000	-14,545,000	-22,807,000	39,114,000	1,123,000	2,293,000	2,331,000	7,308,000	552,000			900,000	-1,747,000	-1,018,000	11,101,000	-4,846,000	-94,364,000	64,661,000
cash and cash equivalents, beginning of period												0	0	112,666,000	0	0	0	82,985,000	0	0	0	36,433,000	0	0	0	42,256,000	0	0	0	125,206,000	0	0	0	66,874,000	0	0	0	65,076,000	0	0	0	20,215,000	0	0	0	20,158,000	0	14,907,000	18,833,000	-8,047,000	25,561,000	77,177,000	39,387,000
cash and cash equivalents, end of period												12,607,000	-21,791,000	115,422,000	22,104,000	53,408,000	-7,440,000	44,594,000	-117,827,000	139,678,000	11,358,000	49,776,000	-3,201,000	5,273,000	-5,048,000	39,409,000	14,632,000	-19,331,000	-68,056,000	115,011,000	8,886,000	15,609,000	51,347,000	49,364,000	36,574,000	2,576,000	-14,545,000	42,269,000	39,114,000	1,123,000	2,293,000	22,546,000	7,308,000	552,000	-901,000	13,256,000	900,000	13,160,000	17,815,000	3,054,000	20,715,000	-17,187,000	104,048,000
depreciation and amortization of property and equipment													1,407,000	1,341,000	734,000	462,000	543,000	537,000	471,000	536,000	416,000	408,000											439,000	421,000	224,000	177,000	170,000	170,000	151,000	146,000	147,000	145,000	137,000	126,000	122,000	105,000	88,000	124,000	178,000	324,000	489,000	519,000	755,000
net decrease in cash and cash equivalents																							-3,201,000	5,273,000	-5,048,000	-2,847,000				-10,195,000				-17,510,000												-6,902,000
non-cash stock-based compensation expense														8,985,000	6,711,000	7,767,000	7,093,000	5,261,000	4,877,000	4,692,000	4,527,000	3,524,000
contract assets																							0	575,000	1,897,000	2,082,000	-8,383,000	4,499,000	5,826,000	3,212,000
proceeds from stock-based award activities																		-3,596,000	2,132,000
net proceeds from long-term debt, net of debt discount and issuance costs
net proceeds from convertible notes, net of debt discount and issuance costs
issuance of common stock under at-the-market offering, net of issuance costs
purchase of capped call options associated with convertible notes
non-cash interest expense on liability related to sale of future royalties																2,985,000	2,900,000	2,822,000	5,673,000	5,481,000	5,932,000	5,706,000	5,533,000	5,321,000	5,064,000	4,819,000	4,741,000	4,559,000	4,338,000	4,129,000	4,074,000	3,918,000	3,729,000	2,307,000
right-of-use assets recognized in exchange for lease obligations																0	5,321,000	77,887,000	0	0	0	1,106,000	0	0
operating lease right-of-use assets																	2,002,000	1,124,000			1,042,000	1,016,000	921,000	898,000	877,000	856,000
operating lease and other non-current liabilities
prepaid and other current assets																			-2,477,000
operating lease right-of-use assets and other assets																			-1,884,000
contract liabilities																											0	-8,132,000	-1,416,000	-9,202,000
sales of property and equipment
proceeds from issuance under employee stock purchase plan
net proceeds from long-term debt, net of debt discount and issuance cost																								0
proceeds from stock based award activities																								459,000
sales and maturities of investments																						55,122,000	32,125,000	56,325,000	56,149,000	61,196,000	78,500,000	59,255,000	63,856,000	44,621,000
proceeds from and payments for stock based award activities																						-2,162,000
issuance of common stock under at the market offering, net of issuance costs																							0	11,400,000
issuance of warrants in connection with long-term debt																							0	0
non-cash equity-related expense																								2,783,000	2,819,000	2,282,000		2,572,000	2,505,000	2,403,000
supplemental cash flow disclosure - non-cash investing and financing activity:
public offerings of common stock, net of issuance costs																										5,117,000
proceeds from common stock award exercise																										31,000
issuance of equity for stock-based awards and warrants																										-732,000		329,000	2,978,000	-524,000
right-of-use assets obtained in exchange for lease obligations																										10,686,000
stock-based compensation																																2,447,000	2,219,000	1,922,000	1,880,000	1,866,000	1,789,000	1,611,000	1,348,000	1,121,000	1,202,000	896,000	886,000	891,000	859,000	694,000	656,000	966,000	943,000	498,000	994,000	1,713,000	1,160,000
net gain on disposal of equipment
non-cash interest expense related to long-term debt																													411,000	177,000	217,000	140,000	139,000	139,000
proceeds from public offerings of common stock, net of issuance costs																															0	-8,000	94,877,000	17,355,000									9,102,000	0	0	39,869,000
proceeds from sale of future royalties, net of issuance costs																															0	0	0	90,621,000
proceeds from issuance of common stock related to sale of future royalties, net of issuance costs																															0	0	0	7,560,000
proceeds from stock based award activities and warrants																															933,000	1,442,000
supplemental disclosure of cash flow information
cash paid for taxes
(gain) loss on disposal of equipment
sale of future royalties, net of issuance costs
issuance of common stock related to sale of future royalties, net of issuance costs
issuance of long term debt, net of debt discount and issuance costs
net cash from in investing activities																														20,136,000
non-cash stock-based compensation
gain on sale of investments																																							-2,000				0	0
net proceeds from long term debt, net of debt discount and issuance costs
proceeds from sales and maturities of investments																																53,035,000	45,070,000	21,858,000	24,073,000	23,536,000	16,631,000	30,405,000	46,522,000	40,362,000	27,429,000	17,877,000	20,350,000	15,724,000	41,081,000	26,943,000	17,203,000	18,408,000	15,667,000	-3,464,000	40,810,000	-18,501,000	31,077,000
proceeds from sale of property and equipment																																				1,000
proceeds from long term debt, net of debt discount and issuance costs																																			0	0	0	14,996,000
gain on disposal of equipment																																	0	-82,000
related party accounts receivable																																		-885,000	66,976,000	-66,974,000	-26,000	12,000	36,000	-43,000	965,000	45,676,000				-2,111,000		-324,000	-69,000	-150,000	169,000	-41,913,000	41,938,000
proceeds (payments) from stock based award activities and warrants																																		198,000	715,000	727,000	589,000	-135,000
non-cash interest expense																																			139,000	138,000	138,000	119,000														23,000	23,000
proceeds from sales of property and equipment																																															10,000
loss on disposal of property and equipment																																																					3,000
gain on disposal of property and equipment
amortization of debt discount
related party payables and accrued liabilities																																															0	-150,000	-12,000	1,000	10,000	33,000	-49,000
payments from stock based award activities and warrants																																											32,000
proceeds(payments) from stock based award activities and warrants																																									41,000	65,000
non-cash restructuring expenses, net of reversals																																																	-41,000
decrease in restricted cash
proceeds from draw down of committed equity financing facilities and at-the-market facility, net of commission and issuance costs																																																	2,819,000
proceeds from issuance of preferred stock, net of issuance costs
repayment of equipment financing lines																																																	-152,000	-72,000	-424,000	-1,200,000	-885,000
accounts receivable and related party accounts receivable																																												-871,000
loss on disposal of equipment
license fee receivable
proceeds (payments) from stock based award activities, and warrants																																														-89,000
proceeds from initial public offering, sale of common stock to related party, and public offerings, net of issuance costs																																															0
proceeds from other issuances of common stock and warrants																																															7,516,000	5,000
non-cash impairment charges
non-cash forgiveness of loans to officers
non-cash warrant expense
other non-cash expenses
proceeds from sales of auction rate securities
issuance of related party notes receivable
proceeds from repayments of notes receivable
repurchase of common stock
proceeds from loan with ubs
repayment of loan with ubs																																																			-328,000
proceeds from equipment financing lines																																																					1,743,000
non-cash forgiveness of loan to officers
tax benefit from stock-based compensation
tax expense from stock-based compensation
increase in restricted cash																																																	145,000	-92,000	441,000	1,111,000	-91,000
proceeds from other issuances of common stock and warrants, net of issuance costs
accrued liabilities																																																		47,000	-1,643,000	367,000	-916,000
proceeds from draw down of committed equity financing and at-the-market facility, net of issuance costs
non-cash forgiveness of loan to officer
proceeds from draw down of committed equity financing facility, net of issuance costs																																																			3,370,000
proceeds from other issuances of common stock																																																			40,000	190,000	141,000
non-cash restructuring expenses
proceeds from initial public offering, sale of common stock to related party and public offerings, net of issuance costs
allowance for doubtful accounts
non-cash expense related to warrants issued for equipment financing lines and facility lease
proceeds from payments of related party notes receivable
non-cash expense for acceleration of options
proceeds from payments of notes receivable
proceeds from initial public offering, net of issuance costs
proceeds from sale of common stock to related party, net of issuance costs																																																					26,009,000
proceeds from public offerings, net of issuance costs																																																					-7,000
non-cash compensation expense for acceleration of options
proceeds from sale of common stock to related party
related party accrued liabilities
operating activities
depreciation and amortization
gain or loss on sale of property and equipment
non-cash proceeds from sale of property and equipment
related party receivable
prepaids and other current assets
other assets
investing activities
investment in restricted cash
issuance of notes receivable
purchases of short-term and long-term investments
financing activities
repayment of equipment loan
proceeds from issuance of common stock
proceeds from issuance of preferred stock
additional equipment loan taken
increase in cash and cash equivalents
supplemental disclosure of cash flow information:
supplemental disclosure of significant non-cash investing and financing activities:
deferred stock-based compensation
penalty on restructuring

We provide you with 20 years of cash flow statements for Cytokinetics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Cytokinetics stock. Explore the full financial landscape of Cytokinetics stock with our expertly curated income statements.

The information provided in this report about Cytokinetics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.